Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/262129 
Erscheinungsjahr: 
2022
Schriftenreihe/Nr.: 
Research Paper No. 154
Verlag: 
South Centre, Geneva
Zusammenfassung: 
In the context of a health emergency like the COVID-19 pandemic, the global availability of and access to vaccines are imperative. This research paper provides an analysis from the perspective of international political economy, of the financing of COVID-19 vaccines and of the market strategies adopted by some of the companies that developed them. It notes that the development of vaccines was supported by substantial public funding from countries that later received preferential access to those vaccines through advance purchases. Despite such public support, the vaccines were not deemed as public goods but remained under the control of their developers.
Schlagwörter: 
Access to Vaccines
Advance Purchases
COVID-19
Global Common Goods
Global Health
Global Public Good
Global South
Health
Intellectual Property
Pandemic
Patent
Public Health
Vaccine Financing
Vaccines
Dokumentart: 
Research Report
Erscheint in der Sammlung:

Datei(en):
Datei
Größe
4.97 MB





Publikationen in EconStor sind urheberrechtlich geschützt.